Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease

Histone deacetylases (HDACs) are currently being discussed as promising therapeutic targets to treat neurodegenerative diseases. However, the role of specific HDACs in cognition and neurodegeneration remains poorly understood. Here, we investigate the function of HDAC6, a class II member of the HDAC...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Govindarajan, Nambirajan, Rao, Pooja, Burkhardt, Susanne, Sananbenesi, Farahnaz, Schlüter, Oliver M, Bradke, Frank, Lu, Jianrong, Fischer, André
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: WILEY-VCH Verlag 2013
Gaiak:
Research Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3569653/
https://ncbi.nlm.nih.gov/pubmed/23184605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/emmm.201201923
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak